Rise of polycatecholamine ultrathin films: From synthesis to smart applications
Source abstract
Abstract
Abstract Ultrathin polymeric films are fundamental for modern technologies, with applications spanning from protective coatings, membranes, to electronic interfaces. The need to optimize the synthesis and functionalization of nanometer-thick films fuels ongoing scientific and industrial innovation. Among emerging polymeric materials, polycatecholamines have attracted increasing interest as versatile two-dimensional (2D) ultrathin coatings, owing to their distinctive chemical structure and strong adhesion properties, qualities that have earned them the designation of “universal coatings.” This review highlights the molecular architecture of catecholamine-derived polymeric networks and evaluates key synthesis and functionalization strategies for ultrathin coating and free-standing film fabrication. Methods such as layer-by-layer assembly, solution-based deposition, and surface-initiated polymerization are critically assessed. We further examine the application potential of these coatings in diverse areas, including membrane technology, catalytic support frameworks, biosensing, and soft robotics. Recent advances are presented alongside a discussion of current limitations, particularly regarding their stability and scalability. Finally, we outline future directions for research and development in nanocoating technologies, emphasizing the role of functional nanomaterial design and interdisciplinary applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Surface Modification and Superhydrophobicity · Advanced Sensor and Energy Harvesting Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department for Synthesis of Macromolecules, Max Planck Institute for Polymer Research , 55128 , Mainz , Germany
Department of Chemistry and State Research Center OPTIMAS, RPTU Kaiserslautern-Landau , 67663 , Kaiserslautern , Germany
Institute of Physical Chemistry, Christian-Albrechts-University Kiel , 24118 , Kiel , Germany
References (100+)
Show source-provided references
1. Ranzoni A, Cooper MA. The growing influence of nanotechnology in our lives. Micro- and nanotechnology in vaccine development. New York, USA: Elsevier Inc; 2017. p. 1–20.10.1016/B978-0-323-39981-4.00001-4 ↗
2. Stadermann M, Baxamusa SH, Aracne-Ruddle C, Chea M, Li S, Youngblood K, et al. Fabrication of large-area free-standing ultrathin polymer films. J Vis Exp. 2015;100:e52832.10.3791/52832 ↗
3. Endo H, Mitsuishi M, Miyashita T. Free-standing ultrathin films with universal thickness from nanometer to micrometer by polymer nanosheet assembly. J Mater Chem. 2008;18(12):1302.10.1039/b717080g ↗
4. Łempicka‐Mirek K, Król M, Mazur R, Piecek W, Szczytko J, Majewski PW, et al. Free‐standing ultrathin films of 2D perovskite for light‐emitting devices operating at strong coupling regime. Adv Opt Mater. 2025;13(2):2401666.10.1002/adom.202401666 ↗
5. Lehner BAE, Benz D, Moshkalev SA, Meyer AS, Cotta MA, Janissen R. Biocompatible graphene oxide nanosheets densely functionalized with biologically active molecules for biosensing applications. ACS Appl Nano Mater. 2021;4(8):8334–42.10.1021/acsanm.1c01522 ↗
6. Missale E, Frasconi M, Pantano MF. Ultrathin organic membranes: Can they sustain the quest for mechanically robust device applications? iScience. 2023;26(2):105924.10.1016/j.isci.2023.105924 ↗
7. Meng Z, Stolz RM, Mendecki L, Mirica KA. Electrically-transduced chemical sensors based on two-dimensional nanomaterials. Chem Rev. 2019; 119:478–598. American Chemical Society.10.1021/acs.chemrev.8b00311 ↗
8. Yu J, Marchesi D’Alvise T, Harley I, Krysztofik A, Lieberwirth I, Pula P, et al. Ion and molecular sieving with ultrathin polydopamine nanomembranes. Adv Mater. 2024;36(29):2401137.10.1002/adma.202401137 ↗
9. Yang K, Zhang P, Feng Z, Wang Y, Peng J, Li B. Solution‐processed nanocoating of Ca2Nb3O10 and polydopamine for anticorrosion on magnesium alloy. Adv Eng Mater. 2024;26(11):2400223.10.1002/adem.202400223 ↗
10. Van Tassel PR. Nanotechnology in medicine: Nanofilm biomaterials. Yale J Biol Med. 2013;86(4):527–36.
11. Piedade AP, Romeu F, Branco R, Morais PV. Thin films for medical and environmental applications. Methods for film synthesis and coating procedures. London, UK: IntechOpen; 2020. p. 1–13.
12. Gao S, Wang D, Fang W, Jin J. Ultrathin membranes: a new opportunity for ultrafast and efficient separation. Adv Mater Technol. 2020;5(4):1–15.10.1002/admt.201901069 ↗
13. Deng X, Gould M, Ali MA. A review of current advancements for wound healing: Biomaterial applications and medical devices. J Biomed Mater Res B Appl Biomater. 2022;110(11):2542–73.10.1002/jbm.b.35086 ↗
14. de Carvalho ACW, Paiva NF, Demonari IK, Duarte MPF, do Couto RO, de Freitas O, et al. The potential of films as transmucosal drug delivery systems. Pharmaceutics. 2023;15(11):2583.10.3390/pharmaceutics15112583 ↗
15. Oyola-Reynoso S, Wang Z, Chen J, Çınar S, Chang B, Thuo M. Revisiting the challenges in fabricating uniform coatings with polyfunctional molecules on high surface energy materials. Coatings. 2015;5(4):1002–18.10.3390/coatings5041002 ↗
16. Ariga K, Yamauchi Y, Mori T, Hill JP. 25th Anniversary article: What can be done with the Langmuir-Blodgett method? Recent developments and its critical role in materials science. Adv Mater. 2013;25(45):6477–512.10.1002/adma.201302283 ↗
17. Borges J, Mano JF. Molecular interactions driving the layer-by-layer assembly of multilayers. Chem Rev. 2014;114(18):8883–942.10.1021/cr400531v ↗
18. Wei Q, Becherer T, Angioletti-Uberti S, Dzubiella J, Wischke C, Neffe AT, et al. Protein interactions with polymer coatings and biomaterials. Angew Chem – Int Ed. 2014;53(31):8004–31.10.1002/anie.201400546 ↗
19. Prashar D. Self assembled monolayers - A review. Int J Chemtech Res. 2012;4(1):258–65.
20. Galuska LA, Muckley ES, Cao Z, Ehlenberg DF, Qian Z, Zhang S, et al. SMART transfer method to directly compare the mechanical response of water-supported and free-standing ultrathin polymeric films. Nat Commun. 2021;12(1):2347.10.1038/s41467-021-22473-w ↗
21. Fujie T. Development of free-standing polymer nanosheets for advanced medical and health-care applications. Polym J. 2016;48(7):773–80.10.1038/pj.2016.38 ↗
22. Chiong JA, Tran H, Lin Y, Zheng Y, Bao Z. Integrating emerging polymer chemistries for the advancement of recyclable, biodegradable, and biocompatible electronics. Adv Sci. 2021;8(14):2101233.10.1002/advs.202101233 ↗
23. Kleinschmidt AT, Lipomi DJ. Stretchable conjugated polymers: a case study in topic selection for new research groups. Acc Chem Res. 2018;51(12):3134–43.10.1021/acs.accounts.8b00459 ↗
24. Gupta V, Biswas D, Roy S. A comprehensive review of biodegradable polymer-based films and coatings and their food packaging applications. Materials. 2022;15(17):5899.10.3390/ma15175899 ↗
25. Doppalapudi S, Jain A, Khan W, Domb AJ. Biodegradable polymers – an overview. Polym Adv Technol. 2014;25(5):427–35.10.1002/pat.3305 ↗
26. Barclay TG, Hegab HM, Clarke SR, Ginic‐Markovic M. Versatile surface modification using polydopamine and related polycatecholamines: chemistry, structure, and applications. Adv Mater Interfaces. 2017;4(19):1601192.10.1002/admi.201601192 ↗
27. Nagatsu T. The catecholamine system in health and disease -Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes. Proc Jpn Acad Ser B. 2006;82(10):388–415.10.2183/pjab.82.388 ↗
28. Tiu BDB, Delparastan P, Ney MR, Gerst M, Messersmith PB. Cooperativity of catechols and amines in high‐performance dry/wet adhesives. Angew Chem. 2020;59(38):16759–67.10.1002/ange.202005946 ↗
29. Maier GP, Rapp MV, Waite JH, Israelachvili JN, Butler A. Adaptive synergy between catechol and lysine promotes wet adhesion by surface salt displacement. Science (1979). 2015;349(6248):628–32.10.1126/science.aab0556 ↗
30. Lee H, Dellatore SM, Miller WM, Messersmith PB. Mussel-inspired surface chemistry for multifunctional coatings. Science (1979). 2007;318(5849):426–30.10.1126/science.1147241 ↗
31. Silverman HG, Roberto FF. Understanding marine mussel adhesion. Mar Biotechnol. 2007;9(6):661–81.10.1007/s10126-007-9053-x ↗
32. Ding Y, Weng LT, Yang M, Yang Z, Lu X, Huang N, et al. Insights into the aggregation/deposition and structure of a polydopamine film. Langmuir. 2014;30(41):12258–69.10.1021/la5026608 ↗
33. Ryu JH, Messersmith PB, Lee H. Polydopamine surface chemistry: a decade of discovery. ACS Appl Mater Interfaces. 2018;10(9):7523–40.10.1021/acsami.7b19865 ↗
34. Zhang C, Gong L, Xiang L, Du Y, Hu W, Zeng H, et al. Deposition and adhesion of polydopamine on the surfaces of varying wettability. ACS Appl Mater Interfaces. 2017;9(36):30943–50.10.1021/acsami.7b09774 ↗
35. Tan X, Gao P, Li Y, Qi P, Liu J, Shen R, et al. Poly-dopamine, poly-levodopa, and poly-norepinephrine coatings: Comparison of physico-chemical and biological properties with focus on the application for blood-contacting devices. Bioact Mater. 2021;6(1):285–96.10.1016/j.bioactmat.2020.06.024 ↗
36. Michalicha A, Tomaszewska A, Vivcharenko V, Budzyńska B, Kulpa-Greszta M, Fila D, et al. Poly(levodopa)-functionalized polysaccharide hydrogel enriched in Fe3O4 particles for multiple-purpose biomedical applications. Int J Mol Sci. 2023;24(9):8002.10.3390/ijms24098002 ↗
37. Krysztofik A, Warżajtis M, Pochylski M, Boecker M, Yu J, Marchesi D’Alvise T, et al. Multi-responsive poly-catecholamine nanomembranes. Nanoscale. 2024;16(34):16227–37.10.1039/D4NR01050G ↗
38. Ishino K, Nishitani S, Man Y, Saito A, Sakata T. Surface characteristics and formation of polyserotonin thin films for bioelectrical and biocompatible interfaces. Langmuir. 2022;38(28):8633–42.10.1021/acs.langmuir.2c01045 ↗
39. Jeon K, Asuncion JA, Corbett AL, Yuan T, Patel M, Andoy NMO, et al. Buffer components incorporate into the framework of polyserotonin nanoparticles and films during synthesis. Nanomaterials. 2022;12(12):2027.10.3390/nano12122027 ↗
40. Nakatsuka N, Hasani-Sadrabadi MM, Cheung KM, Young TD, Bahlakeh G, Moshaverinia A, et al. Polyserotonin nanoparticles as multifunctional materials for biomedical applications. ACS Nano. 2018;12(5):4761–74.10.1021/acsnano.8b01470 ↗
41. Jeon K, Andoy NMO, Schmitt CW, Xue Y, Barner L, Sullan RMA. Size-controlled synthesis of bioinspired polyserotonin nanoparticles with free radical scavenging activity. J Mater Chem B. 2021;9(3):634–7.10.1039/D0TB02383C ↗
42. Lu Z, Teo BM, Tabor RF. Recent developments in polynorepinephrine: an innovative material for bioinspired coatings and colloids. J Mater Chem B. 2022;10(39):7895–904.10.1039/D2TB01335E ↗
43. Marchesi D’Alvise T, Sunder S, Hasler R, Moser J, Knoll W, Synatschke CV, et al. Preparation of ultrathin and degradable polymeric films by electropolymerization of 3-amino-l-tyrosine. Macromol Rapid Commun. 2022;2200332:1–12.10.26434/chemrxiv-2021-k4rwx ↗
44. Klosterman L, Ahmad Z, Viswanathan V, Bettinger CJ. Synthesis and measurement of cohesive mechanics in polydopamine nanomembranes. Adv Mater Interfaces. 2017;4(10):1700041.10.1002/admi.201700041 ↗
45. Lee H, Rho J, Messersmith PB. Facile conjugation of biomolecules onto surfaces via mussel adhesive protein inspired coatings. Adv Mater. 2009;21(4):431–4.10.1002/adma.200801222 ↗
46. Zmerli I, Michel JP, Makky A. Multifunctional polydopamine-based nanoparticles: synthesis, physico-chemical properties and applications for bimodal photothermal/photodynamic therapy of cancer. Multifunct Mater. 2021;4(2):022001.10.1088/2399-7532/abf0fa ↗
47. Mei S, Xu X, Priestley RD, Lu Y. Polydopamine-based nanoreactors: synthesis and applications in bioscience and energy materials. Chem Sci. 2020;11(45):12269–81.10.1039/D0SC04486E ↗
48. Cheng W, Zeng X, Chen H, Li Z, Zeng W, Mei L, et al. Versatile polydopamine platforms: synthesis and promising applications for surface modification and advanced nanomedicine. ACS Nano. 2019;13(8):8537–65.10.1021/acsnano.9b04436 ↗
49. Ball V, Hirtzel J, Leks G, Frisch B, Talon I. Experimental methods to get polydopamine films: a comparative review on the synthesis methods, the films’ composition and properties. Macromol Rapid Commun. 2023;44(16):2200946.10.1002/marc.202200946 ↗
50. Ponzio F, Ball V. Polydopamine deposition at fluid interfaces. Polym Int. 2016;65(11):1251–7.10.1002/pi.5124 ↗
51. Ambekar RS, Kandasubramanian B. A polydopamine-based platform for anti-cancer drug delivery. Biomater Sci. 2019;7(5):1776–93.10.1039/C8BM01642A ↗
52. Batul R, Tamanna T, Khaliq A, Yu A. Recent progress in the biomedical applications of polydopamine nanostructures. Biomater Sci. 2017;5(7):1204–29.10.1039/C7BM00187H ↗
53. Wang Z, Duan Y, Duan Y. Application of polydopamine in tumor targeted drug delivery system and its drug release behavior. J Control Release. 2018;290:56–74.10.1016/j.jconrel.2018.10.009 ↗
54. Omidian H, Wilson RL. Polydopamine applications in biomedicine and environmental science. Materials. 2024;17(16):3916.10.3390/ma17163916 ↗
55. Li Y, Li C, Yu R, Ding Y. Application of polydopamine on the implant surface modification. Polym Bull. 2022;79(8):5613–33.10.1007/s00289-021-03793-9 ↗
56. Lamaoui A, Lahcen AA, Amine A. Unlocking the potential of molecularly imprinted polydopamine in sensing applications. Polymers (Basel). 2023;15(18):3712.10.3390/polym15183712 ↗
57. Qu K, Wang Y, Vasileff A, Jiao Y, Chen H, Zheng Y. Polydopamine-inspired nanomaterials for energy conversion and storage. J Mater Chem A Mater. 2018;6(44):21827–46.10.1039/C8TA05245J ↗
58. Laverty R. Catecholamines: Role in health and disease. Drugs. 1978;16:418–40. Springer.10.2165/00003495-197816050-00003 ↗
59. Millan MJ. Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs. Neurotherapeutics. 2009;6(1):53–77.10.1016/j.nurt.2008.10.039 ↗
60. Central Nervous System | CK-12 Foundation [Internet]. [cited 2024 Apr 4]. Available from: https://www.ck12.org/book/ck-12-biology-concepts/r5/section/13.18/.
61. Kuhar MJ, Couceyro PR, Lambert PD. Biosynthesis of catecholamines. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD, editors. Basic neurochemistry: molecular, cellular and medical aspects. 6th edn. Philadelphia: Lippincott-Raven; 1999.
62. Goldstein DS, Holmes C, Sharabi Y. Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson’s disease and other synucleinopathies. Brain. 2012;135(6):1900–13.10.1093/brain/aws055 ↗
63. Yokota K, Uchida H, Sakairi M, Abe M, Tanaka Y, Tainaka T, et al. Identification of novel neuroblastoma biomarkers in urine samples. Sci Rep. 2021;11(1):4055.10.1038/s41598-021-83619-w ↗
64. Verly IRN, van Kuilenburg ABP, Abeling NGGM, Goorden SMI, Fiocco M, Vaz FM, et al. Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients. Eur J Cancer. 2017;72:235–43.10.1016/j.ejca.2016.12.002 ↗
65. Axelrod J. Catecholamines and hypertension. Clin Sci Mol Med. 1976;51(Suppl.3):415s–21s.10.1042/cs051415s ↗
66. Goldberg LI. Recent advances in the pharmacology of catecholamines. Intensive Care Med. 1977;3(4):233–6.10.1007/BF01641112 ↗
67. White LP. Melanin: a naturally occurring cation exchange material. Nature. 1958;182(4647):1427–8.10.1038/1821427a0 ↗
68. Nosanchuk JD, Valadon P, Feldmesser M, Casadevall A. Melanization of Cryptococcus neoformans in murine infection. Mol Cell Biol. 1999;19(1):745–50.10.1128/MCB.19.1.745 ↗
69. Jacobson ES. Pathogenic roles for fungal melanins. Clin Microbiol Rev. 2000;13(4):708–17.10.1128/CMR.13.4.708 ↗
70. Wakamatsu K, Ito S. Advanced chemical methods in melanin determination. Pigm Cell Res. 2002;15(3):174–83.10.1034/j.1600-0749.2002.02017.x ↗
71. Nosanchuk JD, Casadevall A. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect Immun. 1997;65(5):1836–41.10.1128/iai.65.5.1836-1841.1997 ↗
72. D’Ischia M, Wakamatsu K, Napolitano A, Briganti S, Garcia-Borron JC, Kovacs D, et al. Melanins and melanogenesis: Methods, standards, protocols. Pigm Cell Melanoma Res. 2013;26(5):616–33.10.1111/pcmr.12121 ↗
73. Ito S. High-performance liquid chromatography (HPLC) analysis of Eu- and pheomelanin in melanogenesis control. J Invest Dermatol. 1993;100(2):S166–71.10.1111/1523-1747.ep12465109 ↗
74. Wakamatsu K, Ohtara K, Ito S. Chemical analysis of late stages of pheomelanogenesis: conversion of dihydrobenzothiazine to a benzothiazole structure. Pigm Cell Melanoma Res. 2009;22(4):474–86.10.1111/j.1755-148X.2009.00580.x ↗
75. Ito S, Wakamatsu K. Chemistry of mixed melanogenesis – pivotal roles of dopaquinone†. Photochem Photobiol. 2008;84(3):582–92.10.1111/j.1751-1097.2007.00238.x ↗
76. Ito S. A chemist’s view of melanogenesis. Pigm Cell Res. 2003;16(3):230–6.10.1034/j.1600-0749.2003.00037.x ↗
77. Song W, Yang H, Liu S, Yu H, Li D, Li P, et al. Melanin: insights into structure, analysis, and biological activities for future development. J Mater Chem B. 2023;11(32):7528–43.10.1039/D3TB01132A ↗
78. Saini AS, Melo JS. Biosorption of uranium by melanin: Kinetic, equilibrium and thermodynamic studies. Bioresour Technol. 2013;149:155–62.10.1016/j.biortech.2013.09.034 ↗
79. Kunwar A, Adhikary B, Jayakumar S, Barik A, Chattopadhyay S, Raghukumar S, et al. Melanin, a promising radioprotector: Mechanisms of actions in a mice model. Toxicol Appl Pharmacol. 2012;264(2):202–11.10.1016/j.taap.2012.08.002 ↗
80. Tu YG, Sun YZ, Tian YG, Xie MY, Chen J. Physicochemical characterisation and antioxidant activity of melanin from the muscles of Taihe Black-bone silky fowl (Gallus gallus domesticus Brisson). Food Chem. 2009;114(4):1345–50.10.1016/j.foodchem.2008.11.015 ↗
81. Schweitzer AD, Revskaya E, Chu P, Pazo V, Friedman M, Nosanchuk JD, et al. Melanin-covered nanoparticles for protection of bone marrow during radiation therapy of cancer. Int J Radiat Oncol Biol Phys. 2010;78(5):1494–502.10.1016/j.ijrobp.2010.02.020 ↗
82. Oh JJ, Kim JY, Son SH, Jung WJ, Kim DH, Seo JW, et al. Fungal melanin as a biocompatible broad-spectrum sunscreen with high antioxidant activity. RSC Adv. 2021;11(32):19682–9.10.1039/D1RA02583J ↗
83. Wang Y, Wang X, Li T, Ma P, Zhang S, Du M, et al. Effects of melanin on optical behavior of polymer: from natural pigment to materials applications. ACS Appl Mater Interfaces. 2018;10(15):13100–6.10.1021/acsami.8b02658 ↗
84. Rzepka Z, Buszman E, Beberok A, Wrześniok D. From tyrosine to melanin: Signaling pathways and factors regulating melanogenesis. Postepy Hig Med Dosw. 2016;70:695–708.10.5604/17322693.1208033 ↗
85. Meredith P, Sarna T. The physical and chemical properties of eumelanin. Pigm Cell Res. 2006;19(6):572–94.10.1111/j.1600-0749.2006.00345.x ↗
86. Cheng J, Moss SC, Eisner M, Zschack P. X-ray characterization of melanins – I. Pigm Cell Res. 1994;7(4):255–62.10.1111/j.1600-0749.1994.tb00060.x ↗
87. Zong S, Li L, Li J, Shaikh F, Yang L, Ye M. Structure characterization and lead detoxification effect of carboxymethylated melanin derived from Lachnum Sp. Appl Biochem Biotechnol. 2017;182(2):669–86.10.1007/s12010-016-2353-8 ↗
88. Cordero RJB, Vij R, Casadevall A. Microbial melanins for radioprotection and bioremediation. Microb Biotechnol. 2017;10(5):1186–90.10.1111/1751-7915.12807 ↗
89. Bayram S, Aygün B, Karadayi M, Alaylar B, Güllüce M, Karabulut A. Determination of toxicity and radioprotective properties of bacterial and fungal eumelanin pigments. Int J Radiat Biol. 2023;99(11):1785–93.10.1080/09553002.2023.2204957 ↗
90. Revskaya E, Chu P, Howell RC, Schweitzer AD, Bryan RA, Harris M, et al. Compton scattering by internal shields based on melanin-containing mushrooms provides protection of gastrointestinal tract from ionizing radiation. Cancer Biother Radiopharm. 2012;27(9):570–6.10.1089/cbr.2012.1318 ↗
91. Cao W, Mantanona AJ, Mao H, McCallum NC, Jiao Y, Battistella C, et al. Radical-enriched artificial melanin. Chem Mater. 2020;32(13):5759–67.10.1021/acs.chemmater.0c01573 ↗
92. Vahidzadeh E, Kalra AP, Shankar K. Melanin-based electronics: From proton conductors to photovoltaics and beyond. Biosens Bioelectron. 2018;122:127–39.10.1016/j.bios.2018.09.026 ↗
93. Al Khatib M, Harir M, Costa J, Baratto MC, Schiavo I, Trabalzini L, et al. Spectroscopic characterization of natural melanin from a Streptomyces cyaneofuscatus strain and comparison with melanin enzymatically synthesized by tyrosinase and laccase. Molecules. 2018;23(8):1916.10.3390/molecules23081916 ↗
94. Tran ML, Powell BJ, Meredith P. Chemical and structural disorder in eumelanins: a possible explanation for broadband absorbance. Biophys J. 2006;90(3):743–52.10.1529/biophysj.105.069096 ↗
95. Grieco C, Kohl FR, Hanes AT, Kohler B. Probing the heterogeneous structure of eumelanin using ultrafast vibrational fingerprinting. Nat Commun. 2020;11(1):4569.10.1038/s41467-020-18393-w ↗
96. Sarna T, Sealy RC. Free radicals from eumelanins: Quantum yields and wavelength dependence. Arch Biochem Biophys. 1984;232(2):574–8.10.1016/0003-9861(84)90575-7 ↗
97. Commoner B, Townsend J, Pake GE. Free radicals in biological materials. Nature. 1954;174(4432):689–91.10.1038/174689a0 ↗
98. Chio SS, Hyde JS, Sealy RC. Temperature-dependent paramagnetism in melanin polymers. Arch Biochem Biophys. 1980;199(1):133–9.10.1016/0003-9861(80)90265-9 ↗
99. Grady FJ, Borg DC. Electron paramagnetic resonance studies on melanins. I. The effect of pH on spectra at Q band. J Am Chem Soc. 1968;90(11):2949–52.10.1021/ja01013a036 ↗
100. Blois MS, Zahlan AB, Maling JE. Electron spin resonance studies on melanin. Biophys J. 1964;4(6):471–90.10.1016/S0006-3495(64)86797-7 ↗